Sphera Funds Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Sphera Funds Management’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-6,463	Closed	-$341K	–	129
2018 Q4	$341K	Sell	6,463 -19,106	-75%	-$1.22M	0.04%	95
2018 Q3	$1.74M	Sell	25,569 -1,326	-5%	-$120K	0.2%	88
2018 Q2	$3.18M	Buy	26,895 +1,895	+8%	+$190K	0.44%	69
2018 Q1	$2.07M	Buy	25,000 +11,250	+82%	+$1.28M	0.31%	75
2017 Q4	$2.05M	Buy	+13,750	New	+$1.32M	0.24%	96

Other funds holding SRRA

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sphera Funds Management's SRRA Position: Q1 2019 in Review

Sphera Funds Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q1 2019, closing a stake of 6,463 shares — an estimated $341K sold.

Sphera Funds Management first reported a position in SRRA in Q4 2017 and held it in 5 quarters. The position peaked at $3.18M in Q2 2018. 59 funds tracked by Wall St. Rank hold SRRA as of Q1 2019.

Sphera Funds Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
Sphera Funds Management sold 6,463 Sierra Oncology, Inc. Common Stock shares in Q1 2019, an estimated $341K.
Sphera Funds Management first reported a position in Sierra Oncology, Inc. Common Stock in Q4 2017 and held it in 5 quarters.
Sphera Funds Management's Sierra Oncology, Inc. Common Stock position peaked at $3.18M in Q2 2018.
59 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q1 2019.

Based on Sphera Funds Management's 13F filing for Q1 2019, filed 15 May 2019.